A case of secondary syphilis
Krishna Prasanth Baalann, Mahalakshmi Krishnan
Corresponding author: Krishna Prasanth Baalann, Department of Community Medicine, Sree Balaji Medical College and Hospital, Bharath Institute of Higher Education and Research, Chennai, India
Received: 29 Dec 2021 - Accepted: 04 Jun 2022 - Published: 24 Jun 2022
Domain: Infectious diseases epidemiology,Dermatology
Keywords: Sexually transmitted diseases, secondary syphilis, macular rash
©Krishna Prasanth Baalann et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Krishna Prasanth Baalann et al. A case of secondary syphilis. Pan African Medical Journal. 2022;42:151. [doi: 10.11604/pamj.2022.42.151.33017]
Available online at: https://www.panafrican-med-journal.com//content/article/42/151/full
A case of secondary syphilis
&Corresponding author
Syphilis is a chronic inflammatory disease caused by the organism Treponema pallidum (T. pallidum). Secondary syphilis is characterized by a rash that emerges around 3 to 6 weeks after the chancre forms, and may appear before the chancre heals in some cases. Other systemic symptoms may appear, indicating that the infection has migrated to other parts of the body. During the secondary stage, a person is extremely contagious. A 40-year-old man presented to our outpatient department with complaints of generalized weakness, headache, nausea, and arthralgia for the past few weeks. The patient had a history of having sex exclusively with men and had been in a monogamous relationship for the past 8 months. Physical examination revealed macular rash with scarred painless lesions over the glans penis and bilateral submandibular lymphadenopathy. Investigations revealed a positive reactive venereal disease research laboratory (VDRL) test. A fluorescent antibody test for T. pallidum showed positive for T.pallidum specific immunoglobulin G (IgG) antibody. HIV test was negative. For treatment, a single dose of 2.4 million units of Benzathine penicillin G was given intramuscularly and advised for follow-up. Patients with syphilis should have their sexual contacts assessed. Regardless of the results of serology testing, exposure within 90 days of a patient's diagnosis necessitates therapy.
Figure 1: macular rash with scarred painless lesions over the glans penis